_______
OUR NEW PROFILE IS: (Nasdaq: MDGS)
No debt and more than $24 million in cash and equivalents on a consolidated basis
Record revenues of $34.95 million in the first half of 2022, compared to $2.39 million revenues in the first half of 2021
Gross profit reached a record $6.19 million in the first half of 2022, up from a gross profit of $0.6 million in the first half of 2021
MDGS Just Exploded off of the 52 Week Low, Creating a Potential Massive Reversal
CHECK OUT THE LATEST PRESENTATION HERE
_______________________
*****BREAKING NEWS RELEASED THIS MORNING*****
Medigus: Eventer Technologies Signed a Letter of Intent for Spin-Off and an approx. $13 million Reverse Merger
The letter of intent was signed with a Tel-Aviv Stock Exchange listed company to hold 74.99% of the merged company
Tel Aviv, Israel, Nov. 16, 2022 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that its 46.21% owned subsidiary, Eventer Technologies Ltd. (“Eventer”), software company engaged in the development of platforms enabling producers and venues to create virtual conferences and events including a smart ticketing solution, signed a non-binding letter of intent (“LOI”) for a planned securities exchange agreement with AI Conversation Systems Ltd. (TASE: AICS) (“AI Conversation Systems”), an Israeli company traded on the Tel- Aviv Stock Exchange.
According to the LOI, the transaction will only be completed if Eventer is valued at least $13 million, as determined by an independent appraiser.
According to the LOI, Eventer will become a wholly owned subsidiary of AI Conversation Systems, and in exchange, Eventer will receive 74.99% of the issued and outstanding share capital of AI Conversation Systems.
“Eventer is the market leader in its field in Israel and becoming a public company will support its efforts to make its services more accessible,” said Liron Carmel, CEO of Medigus. “As a public company, Eventer is expected to have improved access to capital which should enable it to expand operations and activities in Israel and new markets internationally.”
The securities exchange agreement, if signed, will be subject to customary closing conditions.
Eventer has developed a unique event management system that allows its customers to increase sales volume and reduce the resources invested in marketing tools solely intended to increase exposure and sales. Eventer has an exclusive license to use the Screenz.live platform that offers high-quality video conferencing for thousands of participants.
Hello Everyone, The market is set to open shortly and we have something that we feel is extremely exciting for todays session with many catalysts in play. Our more recent profiles have seen some strong double digit movement. Last Thursdays profile opened at $1.17 and hit 1.42 yesterday for a quick 20% or so in just a few sessions. The Nasdaq alert before that opened at 9.65 and hit 14.79 for potential gains of 53% in just 3 sessions. The profile before that opened .62 and hit .74 on strong news for a potential 20% move or somewhere in-between. Based in Israel, Medigus Ltd. (Nasdaq: MDGS) is a technology company focused on innovative growth partnerships, mainly in advanced medical solutions, digital commerce and electric vehicle markets. Medigus’ affiliations in the medical solutions arena include ownership in Polyrizon Ltd. and ownership in industry 4.0 company, ScoutCam Inc. The Company’s affiliates in digital commerce include Gix Internet Ltd., Jeffs’ Brands Ltd. and Eventer Technologies Ltd. In the electric vehicle market, Charging Robotics Ltd. and Revoltz Ltd. are also part of the Company’s portfolio of technology solution providers.
Medigus: Eventer Generated Record Revenues for the First Nine Months of 2022 Exceeding Full-Year 2021 Revenues
Revenues for the first nine months of 2022 were approx. $1.99 million Tel Aviv, Israel, Nov. 15, 2022 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that its 46.21% owned subsidiary, Eventer Technologies Ltd. (“Eventer”), a software company engaged in the development of platforms enabling producers and venues to create virtual conferences and events with integrated smart ticketing solutions, achieved record financial results for the nine months ended September 30, 2022 (based on non-reviewed financial results provided to Medigus by Eventer). Eventer’s overall turnover from ticket sales for the nine months ended September 30, 2022 was approx. $49 million, an increase of approx. 87% compared to the entire year of 2021. More than 1.6 million tickets were sold using Eventer’s online platform during the first nine months of 2022, and Eventer retained its commission rate through the period at approx. 5%. Eventer’s revenues for the first nine months of 2022 totaled at approx. $1.99 million, an increase of 69% compared to approx. $1.18 million for the full year of 2021. Eventer has developed a unique event management system that allows its customers to increase sales volume and reduce the resources invested in marketing tools solely intended to increase exposure and sales. Eventer has an exclusive license to use the Screenz.live platform that offers high-quality video conferencing for thousands of participants.